Latest

LIVE October 26th, 2021 at 11:00 AM ET
Experts will discuss recent advances in screening strategies to more efficiently identify therapeutic candidates for infectious diseases such as schistosomiasis and COVID-19.

Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.

A GLP-grade non-replicative Leishmania major parasite protects hamsters from lethal leishmaniasis infection, setting the stage for human clinical trials and the first potential vaccine for leishmaniasis.